324 related articles for article (PubMed ID: 35214092)
21. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
Ma H; Jiang Z; Xu J; Liu J; Guo ZN
Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
[TBL] [Abstract][Full Text] [Related]
22. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
23. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
25. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
[TBL] [Abstract][Full Text] [Related]
26. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
27. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
28. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
Kikuchi T; Fukuta T; Agato Y; Yanagida Y; Ishii T; Koide H; Shimizu K; Oku N; Asai T
J Pharm Sci; 2019 Dec; 108(12):3823-3830. PubMed ID: 31520645
[TBL] [Abstract][Full Text] [Related]
30. Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke.
Chen J; Jin J; Li K; Shi L; Wen X; Fang F
Front Cell Neurosci; 2022; 16():868323. PubMed ID: 35480961
[TBL] [Abstract][Full Text] [Related]
31. The application of nanoparticles for neuroprotection in acute ischemic stroke.
Chen L; Gao X
Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
[TBL] [Abstract][Full Text] [Related]
32. Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.
González-Nieto D; Fernández-Serra R; Pérez-Rigueiro J; Panetsos F; Martinez-Murillo R; Guinea GV
Cells; 2020 Apr; 9(5):. PubMed ID: 32357544
[TBL] [Abstract][Full Text] [Related]
33. Dual targeted nanocarrier for brain ischemic stroke treatment.
Zhao Y; Jiang Y; Lv W; Wang Z; Lv L; Wang B; Liu X; Liu Y; Hu Q; Sun W; Xu Q; Xin H; Gu Z
J Control Release; 2016 Jul; 233():64-71. PubMed ID: 27142584
[TBL] [Abstract][Full Text] [Related]
34. Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke.
Li M; Zhou J; Jin W; Li X; Zhang Y
Front Pharmacol; 2018; 9():308. PubMed ID: 29681849
[No Abstract] [Full Text] [Related]
35. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
Simpkins AN; Dias C; Leigh R;
Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
[TBL] [Abstract][Full Text] [Related]
37. Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis.
Wang G; Li Z; Wang G; Sun Q; Lin P; Wang Q; Zhang H; Wang Y; Zhang T; Cui F; Zhong Z
Int J Nanomedicine; 2024; 19():4377-4409. PubMed ID: 38774029
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injury.
Saralkar P; Arsiwala T; Geldenhuys WJ
Int J Pharm; 2020 Mar; 578():119090. PubMed ID: 32004683
[TBL] [Abstract][Full Text] [Related]
39. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
[No Abstract] [Full Text] [Related]
40. Recent Advances in Chemically Engineered Nanostructures Impact on Ischemic Stroke Treatment.
Sri Kanaka Durga Vijayalakshmi G; Puvvada N
ACS Omega; 2023 Dec; 8(48):45188-45207. PubMed ID: 38075770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
